Cambridge researchers develop needle-free universal vaccine to combat future virus variants
Crispy enough to crunch, soft enough to enjoy. A good bake.
Summary
Researchers at the University of Cambridge, led by Professor Jonathan Heeney, have developed a needle-free 'universal vaccine' designed to protect against future virus outbreaks. The new approach aims to overcome the limitations of traditional vaccines by providing broader protection that remains effective even as viruses mutate into new strains, potentially ending the reactive cycle of constantly developing new vaccines for emerging variants.
Key quotes
· 4 pulledWe've converted vaccine development from being reactive to being future proof.
Our vaccines will continue to provide protection against viruses even as they mutate into new strains.
We've overcome the problem of traditional vaccines, which have limited protection.
It means we can escape the constant cycle of chasing the virus.
You might also wanna read
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·11mo ago
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus
bbc.com·3mo ago
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·9mo ago
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bac
med.stanford.edu·3mo ago
Denmark Eliminates Leading Cancer-Causing HPV Strains Following 2008 Vaccine Rollout
Denmark has successfully eliminated infections from the two most dangerous cancer-causing HPV strains (types 16 and 18) following the introd
gavi.org·9mo agoFDA Approves First 100% Effective HIV Prevention Drug with Global Impact
The article discusses the milestone approval of the first HIV prevention drug, lenacapavir (brand name Yeztugo), which offers 100% protectio
newatlas.com·10mo ago